Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
02/2006
02/02/2006WO2006010567A1 Substituted pyrido[3', 2': 4, 5]thieno[3,2-d]pyrimidines and pyrido[3', 2': 4, 5]furo[3, 2, d]pyrimidines used as inhibitors of the pde-4 and/or the release of tnf$g(a)
02/02/2006US20060025461 Triazole derivative
02/02/2006US20060025435 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
02/02/2006US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors
02/02/2006US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/02/2006US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
02/02/2006US20060024704 Detection of markers in nascent proteins
02/02/2006US20060024599 Suitable for use in electrophotography
02/02/2006US20060022584 Red organic ligh-emitting compound and organic light-emitting device comprising the same
02/02/2006CA2573538A1 Inhibitors of vegf receptor and hgf receptor signaling
02/02/2006CA2572121A1 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
02/01/2006EP1620439A1 New polymorphs of olanzapine hydrochloride
02/01/2006EP1620427A1 Carboxamide derivatives as anti-diabetic agents
02/01/2006EP1620425A1 Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
02/01/2006EP1620421A2 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
02/01/2006EP1620401A2 Phenyl substituted cyclic derivatives
02/01/2006EP1620399A1 Indolone-acetamide derivatives, processes for preparing them and their uses
02/01/2006EP1620094A2 Novel chemical compounds
02/01/2006EP1620093A2 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives
02/01/2006EP1619948A1 Sustituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands
02/01/2006CN1729196A Process for producing optically active sulfoxide
02/01/2006CN1729195A Process for the preparation of a pharmaceutically pure polymorphic form I of olanzapine
02/01/2006CN1729191A Pyrazoloquinolines with immunomodulating activity
02/01/2006CN1727343A Substitution thieno[3',2':5,6]-pyridino[4,3-d]-pyrimidine-4(3H)-ketone and preparation method
02/01/2006CN1239158C 2-methyl-thieno-benzodiazepine formulation
01/2006
01/31/2006US6992101 indole and thieno (2,3-B)pyrrole compounds with 1,1-dioxo tetrahydro thiophene or pyran ring; treating diabetes, insulin resistance, diabetic neuropathy, diabetic nephropathy, hypertension, hyperinsulinemia, hyperlipidemia, ischemia
01/31/2006US6992092 Anti-diabetic agents
01/31/2006CA2224635C Pyridine derivatives, process for preparing the same, and intermediate therefor
01/26/2006WO2006008556A1 Imidazole and thiazole derivatives as antiviral agents
01/26/2006WO2006008503A1 Pyrimidothiophene compounds
01/26/2006WO2005085234A3 Bycyclic anthranilamide derivatives useful as insecticides
01/26/2006WO2005073236A3 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors
01/26/2006US20060020018 Side effect reduction; hot flashes, vaginal dryness, osteopenia and osteoporosis; cancers and hyperplasia of the breast, endometrium, cervix and prostate endometriosis, uterine fibroids, osteoarthritis, contraceptive agents; 8-Hydroxy-1,4-dithia-spiro[4.5]dec-7-ene-7-carboxylic Acid Methyl Ester
01/26/2006US20060019977 Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient
01/26/2006CA2574354A1 Imidazole and thiazole derivatives as antiviral agents
01/25/2006EP1619197A1 Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-2,4(1H,3H)diones and -4(3H)ones as well as Pyrido[3',2':4,5]furo[3,2-d]-pyrimidin-2,4(1H,3H)diones und -4(3H)ones as inhibitors of TNF-alpha release
01/25/2006EP1619196A1 Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidines and Pyrido[3',2':4,5]furo[3,2-d]-pyrimidines for use as inhibitors of PDA-4 and/or TNF-alpha release
01/25/2006EP1618113A1 Novel crystalline polymorphs of clopidogrel
01/25/2006EP1618112A1 Heterocyclic mchr1 antagonists
01/25/2006EP1618111A2 Salts of clopidogrel and process for preparation
01/25/2006EP1617806A2 Selective spirocyclic glucocorticoid receptor modulators
01/25/2006CN1724536A Benzothiophene [32-b] indole kind derivative, its preparation method and use
01/24/2006US6989388 Antitumor agents; anticancer agents; antiischemic agents; antiinflamamtory agents
01/24/2006US6989385 Pyrazole compounds useful as protein kinase inhibitors
01/19/2006WO2005117890A3 Thienopyrimidines and thiazolopyrimidines for use in medicine
01/19/2006WO2005105805A9 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof
01/19/2006US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals
01/19/2006US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus
01/19/2006US20060014816 such as: 3-{5-[3-(2-methoxyethoxy)-1-propynyl]-3-thienyl}-6-[(4-methyl-1-piperazinyl)methyl]-1,4-dihydroindeno[1,2-c]pyrazole; diseases resulting from inappropriate activation of the immune system (e.g., autoimmune disorders), allograft rejection, and graft vs. host disease
01/19/2006US20060014748 2-NH-heteroarylimidazoles with antibacterial activity
01/19/2006US20060014220 Multipurpose linker compounds and ligands and process for producing the same
01/19/2006US20060011907 Compounds containing 3,4-methylenedioxythiophene units
01/18/2006EP1615886A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
01/18/2006EP1615885A1 B -fused bicyclic proline derivatives and their use for treating arthritic conditions
01/18/2006EP1246784B9 Reaction of carbonyl compounds with organometallic reagents
01/18/2006CN1723207A Inhibitors of histone deacetylase
01/18/2006CN1723043A 造影剂 Contrast agents
01/18/2006CN1237055C 三唑衍生物 Triazole derivatives
01/18/2006CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/17/2006US6987194 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
01/17/2006US6987120 Pharmaceutical compounds
01/17/2006US6987116 Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
01/17/2006US6987105 Prevent apoptosis; vision defects; central nervous system disorders; antiischemic agents; stroke therapy
01/12/2006WO2006004884A2 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
01/12/2006WO2006004833A2 Pyrrolotriazine kinase inhibitors
01/12/2006WO2006004636A2 Fused heterocyclic kinase inhibitors
01/12/2006WO2006003440A1 3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors
01/12/2006WO2006003096A1 Condensed thiophene derivatives and their use as cyclic glp-1 agonists
01/12/2006WO2005113560A3 THIENO[3,2-b]PYRIDINE-6-CARBONITRILES AS PROTEIN KINASE INHIBITORS
01/12/2006WO2005103037A3 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
01/12/2006WO2005077958A8 Resolution of racemates of methyl alpha-5-[4,5,6,7-tetrahydro[3,2-c]thienopyridyl]-(2-chlorophenyl)acetate
01/12/2006US20060009508 5-alkyl-2-thia-5-azabicyclo[2.2.1]heptan-3-ones or salts thereof which are useful as synthetic intermediates
01/12/2006US20060008856 Mass tags for quantitative analysis
01/12/2006CA2571680A1 Fused heterocyclic kinase inhibitors
01/12/2006CA2570185A1 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects
01/12/2006CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity
01/11/2006EP1614676A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same
01/11/2006EP1613603A2 Migrastatin analogs and uses thereof
01/11/2006EP1338596B1 processes for the preparation of carbapenem-type antibacterial agents
01/11/2006EP1104297B1 Compositions for the treatment of chronic lymphocytic leukemia
01/11/2006CN1720047A PgD2 receptor antagonists for the treatment of inflammatory diseases
01/11/2006CN1235882C Aliphatic amino substituted indole quinoline derivatives, their preparation method and pharmaceutical application
01/10/2006US6984737 Di(het)arylaminothiophene derivatives
01/10/2006US6984644 Treatment of skin disorders using thieno[2,3-D]pyrimidinediones
01/10/2006CA2223918C Pyrrole derivatives and medicinal composition
01/05/2006WO2006000555A2 Novel unsaturated tetracyclic tetrahydrofuran derivatives
01/05/2006WO2005100352A8 Selected cgrp-antagonists, their preparation processes and their use as medicaments
01/05/2006WO2005085194A3 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors
01/05/2006WO2004080976A8 Phthalazinone derivatives
01/05/2006US20060004082 6H-thieno'2, 3-b!pyrrole derivatives as antagonists of gonadotropin releasing hormone (gnrh)
01/05/2006US20060004053 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
01/05/2006US20060004038 Novel compounds
01/05/2006US20060004034 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene
01/05/2006US20060004025 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
01/05/2006US20060004009 Ethylenediamine derivatives
01/05/2006US20060004006 Pyrrolotriazine kinase inhibitors
01/05/2006US20060003987 Compounds and their uses
01/05/2006CA2571012A1 Tricyclic compounds and their use as mglur1 antagonists
01/05/2006CA2570961A1 Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities
01/05/2006CA2568752A1 Novel unsaturated tetracyclic tetrahydrofuran derivatives